Clinical Study of Novel TLR2-Containing CAR-T Cells Targeting CD19 and CD22 for Relapsed/Refractory B-ALL and NHL
Clinical trial NCT06879262 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06879262
- Sponsor
- Tongji Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-15
- Primary completion
- 2028-02-28
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.